» Articles » PMID: 38360239

FRP-XGBoost: Identification of Ferroptosis-related Proteins Based on Multi-view Features

Overview
Publisher Elsevier
Date 2024 Feb 15
PMID 38360239
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis represents a novel form of programmed cell death. Pan-cancer bioinformatics analysis indicates that identifying and modulating ferroptosis offer innovative approaches for preventing and treating diverse tumor pathologies. However, the precise detection of ferroptosis-related proteins via conventional wet-laboratory techniques remains a formidable challenge, largely due to the constraints of existing methodologies. These traditional approaches are not only labor-intensive but also financially burdensome. Consequently, there is an imperative need for the development of more sophisticated and efficient computational tools to facilitate the detection of these proteins. In this paper, we presented a XGBoost and multi-view features-based machine learning prediction method for predicting ferroptosis-related proteins, which was referred to as FRP-XGBoost. In this study, we explored four types of protein feature extraction methods and evaluated their effectiveness in predicting ferroptosis-related proteins using six of the most commonly used traditional classifiers. To enhance the representational power of the hybrid features, we employed a two-step feature selection technique to identify the optimal subset of features. Subsequently, we constructed a prediction model using the XGBoost algorithm. The FRP-XGBoost achieved an accuracy of 96.74 % in 10-fold cross-validation and a further accuracy of 91.52 % in an independent test. The implementation source code of FRP-XGBoost is available at https://github.com/linli5417/FRP-XGBoost.

Citing Articles

Integrated explainable machine learning and multi-omics analysis for survival prediction in cancer with immunotherapy response.

Houssou Hounye A, Xiong L, Hou M Apoptosis. 2024; 30(1-2):364-388.

PMID: 39633110 DOI: 10.1007/s10495-024-02050-4.